• 中国科技论文统计源期刊
  • 中国科技核心期刊
  • 中国高校优秀期刊
  • 安徽省优秀科技期刊

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

三阴性乳腺癌90例临床特征及生存情况分析

张露 ,  郑荣生 ,  汪子书 ,  王俊斌 ,  杨燕

downloadPDF
文章导航 > 蚌埠医学院学报  > 2015,  40 > 4: (434-439)  
引用本文:
shu
Citation:
shu

三阴性乳腺癌90例临床特征及生存情况分析

  • 蚌埠医学院第一附属医院 肿瘤内科, 安徽 蚌埠 233004

    • 作者简介: 张露(1987-),女,住院医师.
    通讯作者: 郑荣生, 主任医师.zhengrongsheng2011@163.com ; 
  • 基金项目:

    安徽省卫生厅自然科学研究基金资助项目(09c172)

  • 中图分类号: R737.9

Clinical characteristics and survival analysis of triple-negative breast cancer in 90 cases

  • Department of Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu Anhui 233004, China

    • Corresponding author: ZHENG Rong-sheng, 主任医师.zhengrongsheng2011@163.com ;

  • CLC number: R737.9

  • 摘要: 目的:分析90例三阴性乳腺癌(TNBC)患者的临床资料,探讨其临床病理特征及影响预后的因素。方法:收集284例经病理科证实的乳腺癌患者的完整临床资料,应用统计学软件回顾性分析TNBC患者的临床病理特征、生存情况及肿瘤复发转移的方式。结果:284例乳腺癌患者中90例为TNBC,随访时间13～84个月。TNBC确诊时年龄比非TNBC(n-TNBC)患者小(P<0.01),TNBC患者确诊时肿瘤长径较n-TNBC患者肿瘤大(P<0.01)。手术时出现腋窝淋巴结转移率较高(P<0.01);TNBC中复发或转移82例,比n-TNBC患者更容易出现局部复发或远处转移(P<0.01)。TNBC比n-TNBC患者更容易发生肝、肺和脑转移(P<0.01)。TNBC组5年无病生存率和总生存率分别为3.3%和71.1%,n-TNBC组分别为4.6%和84.5%。单因素分析显示年龄、家族史、组织学分级、肿块大小、淋巴结转移数、辅助放疗及辅助内分泌治疗情况是影响TNBC与n-TNBC患者复发转移及预后的相关因素。多因素分析表明患者诊断为乳腺癌时年龄、组织学分级、肿瘤大小、腋窝淋巴结转移数均是影响TNBC患者复发转移及预后的独立影响因素。结论:与n-TNBC患者比较,TNBC发病年龄较轻,确诊时淋巴结转移率较高,术后复发转移率较高,多见于肺、肝和脑及5年总生存及无病生存率较低。
    Abstract: Objective:To analyze the clinical data of 90 cases with triple negative breast cancer(TNBC) in order to investigate its clinicopathologic characteristics and prognostic factors.Methods:The clinical data of 284 patients with breast cancer diagnosed by histopathology were collected.The clinicopathologic characteristics, recurrence and metastasis of TNBC were retrospectively analyzed by statistical software.Results:Among 284 breast cancer patients, 90 cases were TNBC, and were followed up for 12-84 months.The age of TNBC patient was young than that of n-TNBC patient(P<0.01), the tumor size in TNBC patient was larger than that in n-TNBC patients(P<0.01).The metastasis rate of axillary lymph node was high.The recurrence and metastasis in 82 cases of TNBC patients were found, the recurrence and distance metastasis in TNBC patients was more than that in n-TNBC patient(P<0.01).The metastases in liver, lung and brain in TNBC patients were more than those in n-TNBC patients(P<0.01).The survival analysis showed than the 5-year disease free survival and overall survival in TNBC group and n-TNBC group were 3.3% ＆ 71.1% and 4.6% ＆ 84.5%, respectively.The results of univariate analysis showed that age, family history, histological grade, tumor size, the number of lymph node metastasis, and adjuvant radio and endocrine therapy affected the recurrence, metastasis and prognosis of TNBC and n-TNBC patients.Multivariate analysis showed the age, histological grade, tumor size, the number of axillary lymph nodes metastasis were independently effective factor in the recurrence, metastasis and prognosis of TNBC patients.Conclusions:Compared with the n-TNBC patients, the TNBC patient is young, nonmenopause, high recurrence and metastasis after surgery(more in liver and bone) and low 3- and 5-year overall survival and disease free survival rates.
  • [1] Zhang L, Hao C, Dong G, et al.Analysis of clinical features and out-come of 356 triple-negative breast cancer patients in china[J]. Breast Care(Basel), 2012, 7(1):13-17.
    [2] 马静.三阴乳腺癌的最新治疗进展[J].中国肿瘤临床, 2011, 38(19):1234-1238.
    [3] Perou CM, Sorlie T, Eisen MB, et al.Molecular portraits of human breast tumors[J].Nature, 2000, 406(6797):747-752.
    [4] Montagna E, Maisonneuve P, Rotmensz N, et al.Heterogeneity of triple-negative breast cancer:histologic subtyping to inform the outcome[J].Clin Breast Cancer, 2013, 13(1):31-39.
    [5] Solie T, Perou CM, Tibshirani R, et al.Gene expression patterns of breast carcinomas distinguish tumors classes with clinical implications[J].Proc Natl Acad Sci USA, 2011, 98(19):10869-10874.
    [6] Cleator S, Hellr W, Coombes RC.Triple-negative breast cancer:therapeutic options[J].Lancet Oncol, 2007, 8(3):235-244.
    [7] Nielsen TO, Hsu FD, Jensen K, et al.Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma[J].Clin Cancer Res, 2004, 10(16):5367.
    [8] Dent R, Trudeau M, Pritchard KI, et al.Triple-negative breast cancer clinical features and patters recurrence[J].Clin Cancer Res, 2007, 13(15):4429-4434.
    [9] Morris GJ, Naidu S, Tppham AK, et al.Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients a single institution complication compared with the National Cancer Institutes Surveillance, Epidemiology, and results databases[J].Cancer, 2007, 110(4):876-884.
    [10] Rakha EA, Reis Filho J, Ellis D.Basal-like breast cancer:a critical review[J].Clin Oncol, 2008, 26(15):2568.
    [11] 孙国贵, 王雅棣, 胡万宁, 等.乳腺癌的诊断现状及最新进展[J].中国综合临床, 2012, 28(12):1255-1260.
    [12] Goldhirsch A, Winer EP, Coates AS, et al.Personalizing the treatment of women with early breast cancer:highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013[J].Ann Oncol, 2013, 24(9):2206-2223.
    [13] Wirapati P, Sotiriou C, Kunkel S, et al.Meta-analysis of gene expression profiles in breast cancer:toward a unified understanding of breast cancer subtyping and prognosis signatures[J].Breast Cancer Res, 2008, 10(4):R65.
    [14] 袁中玉, 王树森, 高岩, 等.305例三阴乳腺癌患者临床特征及预后分析[J].癌症, 2008, 27(6):561-565.
    [15] 何震, 周默巍, 姜吉洵.探讨三阴性乳腺癌的临床病理特征及其预后因素[J].健康之路, 2013, 3(12):55-56.
    [16] Bauer KR, Brown M, Cressr D, et al.Descriptive analysis of estrogen receptor(ER)-negative, progesterone receptor(PR)-negative, and Her2-negative invasive breast cancer, the so-called triple-negative phenotype:a population-based study from the California Cancer Registry[J].Cancer, 2007, 109(9):1721-1728.
    [17] Staudacher L, Cottu PH, Dieras V, et al.Platinum-based chemotherapy in metastatic triple-negative breast cancer:the Institut Curie experience[J].Ann Oncol, 2011, 22(4):848-856.
    [18] Bauer KR, Brown M, Cress RD, et al.Descrip tive analysis of estrogen receptor(ER)-negative, progesterone receptor(PR)-negative, and Her2-negative invasive breast cancer, the so-called triple-negative phenotype:a population-based study from the California cancer Registry[J].Cancer, 2007, 109(9):1721-1728.
    [19] Srivastava N, Gochhait S, de Boer P, et al.Role of H2AX in DNA damage response and human cancers[J].Mutat Res, 2009, 681(2/3):180-188.
    [20] Liedtke C, Mazouni C, Hess KR, et al.Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer[J].Clin Oncol, 2008, 26(8):1275-1281.
    [21] Lose F, Duffy DL, Kay GF, et al.Skewed X chromosome inactivation and breast and ovarian cancer status:evidence for X-linked modifiers of BRCA1[J].J Natl Cancer Inst, 2008, 100(21):1519-1529.
    [22] Sanpaola P, Barbieri V, Genovesi D.Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse in conservatively managed early stage breast cancer:a retrospective clinical study[J].Eur J Surg Oncol, 2011, 37(10):876-882.
    [23] Rhee J, Han SW, Oh DY, et al.The clinicopathologic characteristics and prognostic significance of triple-negativity' in node-negative breast cancer[J].BMC Cancer, 2008, 8:307.
    [24] Bauer KR, Brown M, Cress RD, et al.Descriptive analysis of estrogen receptor(ER)-negative, progesterone receptor(PR)-negative, and HER2-negative invasive breast cancer, the so-called triple negative phenotype:a population-based study from the california cancer registry[J].Cancer, 2007, 109(9):1721-1728.
    [25] Ma K, Chau WW, Wong CH, et al.Triple negative status is a poor prognostic indicator in chinese women with breast cancer:a ten year review[J].Asian Pac J Cancer Prev, 2012, 13(5):2109-2114.
    [26] Rodriguez-Pinilla SM, Sarrio D, Honrado E, et al.Prognostic signifficance of basal-like phenotype and fascin expression in nodenegative invasive breast carcinomas[J].Clin Cancer Res, 2006, 12(5):1533-1539.
  • [1] 沈晓东 , 潘高峰 , 刘维燕 , 丁军彬 . 乳腺癌临床病理特征对预后判断的价值. 蚌埠医学院学报, 2016, 41(12): 1642-1646. doi: 10.13898/j.cnki.issn.1000-2200.2016.12.033
    [2] 李玉龙 , 彭德峰 , 王自豪 , 王志军 , 董慧明 . 三阴性乳腺癌210例临床分析. 蚌埠医学院学报, 2019, 44(9): 1173-1176, 1181. doi: 10.13898/j.cnki.issn.1000-2200.2019.09.009
    [3] 郭伟 , 李洪涛 , 张明亮 . 乳腺癌STAT3蛋白表达及其临床意义. 蚌埠医学院学报, 2009, 34(10): 890-892.
    [4] 单宏杰 , 肖迎利 , 马骖 , 谢长华 , 封杨 , 夏艳 . 肿瘤间质比在乳腺癌预后评估中的价值研究. 蚌埠医学院学报, 2019, 44(12): 1631-1633. doi: 10.13898/j.cnki.issn.1000-2200.2019.12.015
    [5] 杨清 , 陈广业 . Ninjurin2在乳腺癌中的表达及其与预后的关系. 蚌埠医学院学报, 2023, 48(7): 877-880. doi: 10.13898/j.cnki.issn.1000-2200.2023.07.005
    [6] 王彬彬 . 三阴性乳腺癌中CXCL13的表达与临床病理及预后的关系. 蚌埠医学院学报, 2018, 43(12): 1575-1577. doi: 10.13898/j.cnki.issn.1000-2200.2018.12.010
    [7] 郑健 , 竺红 . 干燥综合征相关性间质性肺疾病41例临床特点及预后分析. 蚌埠医学院学报, 2016, 41(7): 938-941. doi: 10.13898/j.cnki.issn.1000-2200.2016.07.035
    [8] 杨广娥 , 何远知 , 江亮亮 , 宋从磊 , 杨斌 . 儿童急性播散性脑脊髓炎临床特点及预后影响因素分析. 蚌埠医学院学报, 2021, 46(4): 484-488. doi: 10.13898/j.cnki.issn.1000-2200.2021.04.015
    [9] 徐葵花 , 张莉 , 陈峰 , 王彩红 . 流行性脑脊髓膜炎77例临床预后分析. 蚌埠医学院学报, 2011, 36(11): 1187-1189,1193.
    [10] 孟凡伟 , 赵玉魁 , 郑杰 , 刘勇 . 全脑三维适形放疗对脑转移瘤的疗效及预后影响因素分析. 蚌埠医学院学报, 2018, 43(4): 497-500. doi: 10.13898/j.cnki.issn.1000-2200.2018.04.021
    [11] 王玲玲 , 顾素英 , 杨菊萍 , 高之振 . 乳腺叶状肿瘤的临床及数字化X线征象分析. 蚌埠医学院学报, 2012, 36(1): 77-79.
    [12] 黄云芹 , 黄云生 , 杨维兵 . CD133在乳腺癌组织中的表达及其与微血管密度的关系. 蚌埠医学院学报, 2013, 37(12): 1558-1560.
    [13] 傅晓艳 . 乳腺癌Ki-67抗原表达与腋淋巴结转移和组织学分级的关系. 蚌埠医学院学报, 2005, 30(1): 17-19.
    [14] 彭福 , 骆鹏飞 , 李雷 . 乳腺癌病人术前炎性指标与临床病理特征的相关性分析. 蚌埠医学院学报, 2021, 46(9): 1208-1211, 1215. doi: 10.13898/j.cnki.issn.1000-2200.2021.09.014
    [15] 刘德纯 , 吴礼高 , 赵云霞 , 承泽农 . 乳腺癌分子分类临床病理745例分析. 蚌埠医学院学报, 2011, 36(1): 29-33.
    [16] 周锐 , 黄建康 , 彭德峰 , 朱金海 , 朱正志 , 苏蕾 , 杨丽 . 临床触诊阴性乳腺癌23例误诊分析. 蚌埠医学院学报, 2015, 40(1): 29-31. doi: 10.13898/j.cnki.issn.1000-2200.2015.01.009
    [17] 方仁年 , 戴瑜珍 , 金永海 , 螘国铮 . 乳腺原发性浆细胞瘤2例临床病理分析. 蚌埠医学院学报, 2011, 36(6): 584-586.
    [18] 谷勤勤 , 周蕾 , 龚晓萌 , 谢群 , 王萍 . 乳腺神经内分泌癌3例临床病理分析及文献复习. 蚌埠医学院学报, 2013, 37(2): 145-148.
    [19] 张珂 , 钱军 , 金鑫 , 喻大军 , 陈邦领 . 脂肪溶解液预防乳腺癌术后淋巴漏的临床效果分析. 蚌埠医学院学报, 2015, 40(4): 445-446,449. doi: 10.13898/j.cnki.issn.1000-2200.2015.04.008
    [20] 张广东 , 袁牧 , 张阳 , 李伍好 , 梅琪 , 谭玉林 . 肝动脉化疗栓塞联合微波消融术治疗早中期肝癌疗效分析. 蚌埠医学院学报, 2023, 48(2): 203-206. doi: 10.13898/j.cnki.issn.1000-2200.2023.02.015
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  4057
  • HTML全文浏览量:  683
  • PDF下载量:  314
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-12-30

三阴性乳腺癌90例临床特征及生存情况分析

  • 收稿日期: 2013-12-30
基金项目:  安徽省卫生厅自然科学研究基金资助项目(09c172)

摘要: 目的:分析90例三阴性乳腺癌(TNBC)患者的临床资料,探讨其临床病理特征及影响预后的因素。方法:收集284例经病理科证实的乳腺癌患者的完整临床资料,应用统计学软件回顾性分析TNBC患者的临床病理特征、生存情况及肿瘤复发转移的方式。结果:284例乳腺癌患者中90例为TNBC,随访时间13～84个月。TNBC确诊时年龄比非TNBC(n-TNBC)患者小(P<0.01),TNBC患者确诊时肿瘤长径较n-TNBC患者肿瘤大(P<0.01)。手术时出现腋窝淋巴结转移率较高(P<0.01);TNBC中复发或转移82例,比n-TNBC患者更容易出现局部复发或远处转移(P<0.01)。TNBC比n-TNBC患者更容易发生肝、肺和脑转移(P<0.01)。TNBC组5年无病生存率和总生存率分别为3.3%和71.1%,n-TNBC组分别为4.6%和84.5%。单因素分析显示年龄、家族史、组织学分级、肿块大小、淋巴结转移数、辅助放疗及辅助内分泌治疗情况是影响TNBC与n-TNBC患者复发转移及预后的相关因素。多因素分析表明患者诊断为乳腺癌时年龄、组织学分级、肿瘤大小、腋窝淋巴结转移数均是影响TNBC患者复发转移及预后的独立影响因素。结论:与n-TNBC患者比较,TNBC发病年龄较轻,确诊时淋巴结转移率较高,术后复发转移率较高,多见于肺、肝和脑及5年总生存及无病生存率较低。

English Abstract

    全文HTML

参考文献 (26)

目录

    /

    返回文章
    返回

    版权所有© 2019《蚌埠医学院学报》编辑部 皖ICP备06000434号-1

    地址：安徽省蚌埠市东海大道2600号 邮编：233030

    电话：0552-3175456 Email：byxb@vip.163.com

    本系统由 北京仁和汇智信息技术有限公司 开发 技术支持： info@rhhz.net   百度统计